Analysis on the susceptibility genes in two Chinese pedigrees with familial Parkinson's disease

Neurology Research International

Volumn 2010, Issue , 2010, Pages

  Xu, Changshui ^a   Xu, Jun ^a   Zhang, Yanmin ^a   Ma, Jianjun ^a   Kawakami, Hideshi ^b   Maruyama, Hirofumi ^b   Kamada, Masaki ^b  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868664701     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2010/674740     Document Type: Article

References (17)

1. A. H. V. Schapira, "Etiology and pathogenesis of Parkinson disease," Neurologic Clinics, vol. 27, no. 3, pp. 583-603, 2009.
2. S. T. Camargos, L. O. Dornas, P. Momeni et al., "Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations," Movement Disorders, vol. 24, no. 5, pp. 662-666, 2009.
3. N. Pankratz and T. Foroud, "Genetics of Parkinson disease," Genetics in Medicine, vol. 9, no. 12, pp. 801-811, 2007. (Pubitemid 350295207)
4. S. Asakawa, N. Hattori, A. Shimizu et al., "Analysis of eighteen deletion breakpoints in the parkin gene," Biochem Biophys Res Commun, vol. 389, no. 1, pp. 181-186, 2009.
5. H. Leung and V. Mok, "Parkinson's disease: aetiology, diagnosis, and management," Hong KongMedical Journal, vol. 11, no. 6, pp. 476-489, 2005. (Pubitemid 43109987)
6. Z. Zhang, J.-M. Burgunder, X. An et al., "LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China," Movement Disorders, vol. 24, no. 13, pp. 1902-1905, 2009.
7. E. Sidransky, M. A. Nalls, J. O. Aasly et al., "Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease," The New England Journal of Medicine, vol. 361, no. 17, pp. 1651-1661, 2009.
8. A. Navarro, A. Boveris, M. J. Bández et al., "Human brain cortex:mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies," Free Radical Biology and Medicine, vol. 46, no. 12, pp. 1574-1580, 2009.
9. J. P. M. V. D. Vegt, B. F. L. van Nuenen, B. R. Bloem, C. Klein, and H. R. Siebner, "Imaging the impact of genes on Parkinson's disease," Neuroscience, vol. 164, no. 1, pp. 191-204, 2009.
10. D. B. Calne, B. J. Snow, and C. Lee, "Criteria for diagnosing Parkinson's disease," Annals of Neurology, vol. 32, pp. S125-S127, 1992.
11. S. Nagar, R. C. Juyal, S. Chaudhary et al., "Mutations in the synuclein gene in Parkinson's disease among Indians," Acta Neurologica Scandinavica, vol. 103, no. 2, pp. 120-122, 2001. (Pubitemid 32113106)
12. H. Büeler, "Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease," Experimental Neurology, vol. 218, no. 2, pp. 235-246, 2009.
13. V. Alvarez, A. I. Corao, E. Sánchez-Ferrero et al., "Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease," Neuroscience Letters, vol. 432, no. 1, pp. 79-82, 2008.
14. O. Rothfuss, H. Fischer, T. Hasegawa et al., "Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair," Human Molecular Genetics, vol. 18, no. 20, pp. 3832-3850, 2009.
15. K. S. Rao, "Free radical induced oxidative damage to DNA: relation to brain aging and neurological disorders," Indian Journal of Biochemistry and Biophysics, vol. 46, no. 1, pp. 9-15, 2009.
16. P. M. Abou-Sleiman, M. M. K. Muqit, N. Q. McDonald et al., "A heterozygous effect for PINK1 mutations in Parkinson's disease," Annals of Neurology, vol. 60, no. 4, pp. 414-419, 2006. (Pubitemid 44684977)
17. N. Brueggemann, P. Odin, A. Gruenewald et al., "synuclein gene duplication is present in sporadic Parkinson disease," Neurology, vol. 71, no. 16, p. 1294, 2008.